Gapwaves' net sales and EBITDA, excluding ACI, surpassed Redeye Research estimates (RRe). Also, Hella has achieved the start of production (SOP), marking a significant milestone, although it is financially minor during the ramp-up period expected from 2024-2025. Gapwaves has prepared its organization for higher volumes and is strategically positioned with three signed tier-1 agreements and potentially a fourth. Despite these positive developments, Redeye calibrated its estimates, resulting in a lower fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Gapwaves - On the starting grid

© Modular Finance, source Nordic Press Releases